Intervention
Doxazosin
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 7 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
7 shownThe Effects of Doxazosin and Nifedipine on Blood Pressure Variability and Uric Acid in Plasma in Hypertensive PatientsNCT02563405 · 2015-09-01
UNKNOWNDoxazosin and Ramipril in HypertensionNCT02901977 · 2011-03-01
COMPLETEDOptimum Treatment for Drug-Resistant HypertensionNCT02369081 · 2009-05-01
UNKNOWNEffects of Intensive Long-Term Vasodilation in Hypertensive Patients With Microvascular Angina PectorisNCT00424801 · 2007-01-01
TERMINATEDEffects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential HypertensionNCT00130156 · 2005-10-01
COMPLETEDBlack Education and Treatment of Hypertension (BEAT HTN)NCT00661895 · 2005-08-01
COMPLETEDGenetics of Hypertension Associated Treatments (GenHAT)NCT00006294 · 1999-09-01
COMPLETEDCommon conditions
Leading sponsors
Trial status mix
COMPLETED4
UNKNOWN2
TERMINATED1
Phase mix
PHASE44
NA1
PHASE21
PHASE31
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.